MoFo Life Sciences

October 30, 2018 - United States, Biotech, CFIUS, Pharma, Regulatory
New CFIUS Pilot Program: What Life Sciences Companies and Investors Need to Know
By: Robert S. Litt and Joseph A. Benkert
As many life sciences companies and investors are aware, the U.S. Department of the Treasury (“Treasury”) recently announced a new “pilot program” for the Committee on Foreign Investment in the United States (“CFIUS”) effective November 10, 2018. The pilot program implements certain provisions of
... ›
July 26, 2018 - Agtech, European Union, Regulatory, Intellectual Property
CJEU Raises Bar for Use of CRISPR in Europe's Agribusiness: What You Need to Know
By: Wolfgang Schönig
Today, the Court of Justice of the European Union (“CJEU”) has issued its much awaited decision on the classification of genome-editing tools such as CRISPR/Cas9, Talen or zinc finger within the framework of the EU’s Directive 2001/18/EC on the deliberate release of genetically modified organisms into the environment
... ›
May 16, 2018 - European Union, Regulatory, Intellectual Property
Update on the Implementation of the EU Trade Secrets Directive into German Law
By: Wolfgang Schönig
The EU Trade Secrets Directive, officially titled “Directive (EU) 2016/943 on the protection of undisclosed know-how and business information (trade secrets) against their unlawful acquisition, use and disclosure” (the “TSD”), is a legal instrument by the European Union (EU) that is intended to harmonize
... ›
January 24, 2018 - United States, Startup, Biotech, Pharma, Regulatory, Intellectual Property
Life Sciences Startups: Patent, FDA Considerations
By: Lisa N. Silverman Ph.D.
Innovator companies at all stages seek patent protection in order to limit market competition. Many early-stage companies seek patent protection with the additional goal of attracting investment. However, even if patent filings are accelerated in order to raise funds, it is important that early-stage
... ›
August 02, 2017 - Licensing + Commercial, European Union, Regulatory
IP Licensing and Antitrust Law – What Companies Have to Consider When Doing Business in the U.S. and the EU
By: Jens Hackl, Wolfgang Schönig and Jeff Jaeckel
In both the U.S. and the EU, it is generally acknowledged that the enforcement and commercialization of IP rights must comply with the applicable antitrust laws. This is particularly true for IP licensing. While the majority of provisions in license arrangements will not be
... ›
August 02, 2017 - European Union, Regulatory, Intellectual Property
Harmonization of Trade Secrets in Europe and New U.S. Trade Secrets Law Gets the Green Light
By: Alistair Maughan, Wolfgang Schönig and Bryan Wilson
A harmonized trade secrets protection regime is coming to Europe and the U.S. Until now, the approach to trade secrets across Europe has been fragmented, with some countries having specific trade secrets legislation and others relying on unfair competition, tort, or contract law. Trade
... ›
June 24, 2017 - United States, Pharma, Regulatory, Intellectual Property
Cancer Moonshot: USPTO Extends Cancer Immunotherapy Pilot Program Initiative
By: Karen G Potter Ph.D.
The United States Patent and Trademark Office (PTO) issued a Notice today extending the Cancer Immunotherapy Pilot Program (Pilot Program), also known as “Patents 4 Patients.” The Pilot Program, which accelerates the examination of patent applications directed to cancer immunotherapy methods, will now expire
... ›

Topic Archives: Regulatory

New CFIUS Pilot Program: What Life Sciences Companies and Investors Need to Know

By: Robert S. Litt and Joseph A. Benkert

CJEU Raises Bar for Use of CRISPR in Europe's Agribusiness: What You Need to Know

By: Wolfgang Schönig

Update on the Implementation of the EU Trade Secrets Directive into German Law

By: Wolfgang Schönig

Life Sciences Startups: Patent, FDA Considerations

By: Lisa N. Silverman Ph.D.

IP Licensing and Antitrust Law – What Companies Have to Consider When Doing Business in the U.S. and the EU

By: Jens Hackl, Wolfgang Schönig and Jeff Jaeckel

Harmonization of Trade Secrets in Europe and New U.S. Trade Secrets Law Gets the Green Light

By: Alistair Maughan, Wolfgang Schönig and Bryan Wilson

Cancer Moonshot: USPTO Extends Cancer Immunotherapy Pilot Program Initiative

By: Karen G Potter Ph.D.